民生健康 (301507)

Hangzhou Minsheng Healthcare Co., Ltd.

ASZ

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 35655.43
  • Circulating A-Shares(W): 11018.69
  • Earnings Per Share(RMB): 0.3200
  • Net Assets Per Share(RMB): 4.5428
  • Operating Revenue(W RMB): 62265.14
  • Total Profit(W RMB): 13289.18
  • Net Profit Attributable to Parent(W RMB): 11441.65
  • Net Profit Growth Rate(%): 32.77
  • Weighted Return on Equity(%): 7.2400
  • Operating Cash Flow Per Share(RMB): 0.4440
  • Undistributed Profit Per Share(RMB): 0.7577
  • Capital Reserve Per Share(RMB): 2.6985

2. Main Business

The main business covers:

  • R&D, production, and sales of vitamins, minerals, and other over-the-counter drugs
  • R&D, production, and sales of health foods
  • R&D, production, and sales of functional foods

3. Company Basic Information

  • Company Name: Hangzhou Minsheng Healthcare Co., Ltd.
  • Listing Date: 2023-09-05
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 101 Xintian Road, Donghu Street, Linping District, Hangzhou City, Zhejiang Province
  • Website: www.hzmsjk.com
  • Company Profile: The company, formerly known as Hangzhou Minsheng Healthcare Co., Ltd., was restructured into a joint-stock company in May 2021. It is primarily engaged in the R&D, production, and sales of vitamins and minerals OTC drugs, health foods, and functional foods.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Hangzhou Chaodao Equity Investment Fund Management Co., Ltd. - Hangzhou Hemeng Yizhi Equity Investment Partnership (Limited Partnership) General Legal Person 267.42 2.45
2 Zhejiang Puhua Tianqin Equity Investment Management Co., Ltd. - Lanxi Puhua Lingju Venture Capital Investment Partnership (Limited Partnership) General Legal Person 102.79 0.94
3 Hong Kong Securities Clearing Company Ltd. Northbound Capital 101.59 0.93

5. Concept Sectors

  • New Retail
  • Vitamins
  • Medical Aesthetics Concept
  • Margin Trading & Securities Lending
  • Share Buyback Plan

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information